Central nervous system (CNS) infiltration of pro-inflammatory effector T cells is critical in the development and progression of multiple sclerosis. Here, Lim et al. develop a cationic cell-permeable peptide, dNP2, from the human novel LZAP-binding protein (NLBP), which efficiently delivered proteins into primary mouse and human immune cells in culture, and into the mouse brain in vivo. In mice, intraperitoneal injection of the peptide conjugated to the cytoplasmic domain of cytotoxic T lymphocyte antigen 4 (a T cell receptor with immune-suppressive function) inhibited T cell responses and ameliorated disease symptoms in experimental autoimmune encephalomyelitis.
References
Lim, S. et al. dNP2 is a blood–brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis. Nat. Comm. 6, 8244 (2015)
Rights and permissions
About this article
Cite this article
Crunkhorn, S. Novel peptide ameliorates CNS inflammation. Nat Rev Drug Discov 14, 750 (2015). https://doi.org/10.1038/nrd4777
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4777